Have your own idea? Try our Stock Screener
Polish (WIG) Life Sciences Industry Analysis
UpdatedApr 22, 2026
DataAggregated Company Financials
Companies4
- 7D3.3%
- 3M-13.1%
- 1Y-4.5%
- YTD-13.3%
The Life Sciences industry is up 6.4% in the last week, with Selvita up 6.1%. Overall in the last year, the industry is flat. As for the next few years, earnings are expected to grow by 32% per annum.
Industry Valuation and Performance
Has the Polish Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 22 Apr 2026 | zł1.3b | zł459.0m | -zł102,646,524.00 | 790.2x | -12.3x | 2.7x |
| Fri, 20 Mar 2026 | zł1.2b | zł464.6m | -zł124,641,157.00 | n/a | -9.6x | 2.6x |
| Sun, 15 Feb 2026 | zł1.4b | zł464.6m | -zł124,641,157.00 | n/a | -11.3x | 3x |
| Tue, 13 Jan 2026 | zł1.5b | zł464.6m | -zł124,641,157.00 | n/a | -12.2x | 3.3x |
| Thu, 11 Dec 2025 | zł1.5b | zł464.6m | -zł124,641,157.00 | n/a | -11.8x | 3.2x |
| Sat, 08 Nov 2025 | zł1.4b | zł507.6m | -zł114,663,001.00 | 1590.8x | -11.8x | 2.7x |
| Mon, 06 Oct 2025 | zł1.4b | zł507.7m | -zł114,663,001.00 | 1460.5x | -12.3x | 2.8x |
| Wed, 03 Sep 2025 | zł1.4b | zł460.9m | -zł129,094,851.00 | 37.8x | -10.7x | 3x |
| Fri, 01 Aug 2025 | zł1.5b | zł461.1m | -zł128,888,382.00 | 39x | -11.6x | 3.3x |
| Sun, 29 Jun 2025 | zł1.4b | zł457.8m | -zł130,948,382.00 | n/a | -10.5x | 3x |
| Tue, 27 May 2025 | zł1.4b | zł457.8m | -zł130,428,382.00 | n/a | -10.9x | 3.1x |
| Thu, 24 Apr 2025 | zł1.5b | zł452.3m | -zł123,092,243.00 | 49.3x | -12.6x | 3.4x |
| Sat, 22 Mar 2025 | zł1.5b | zł440.9m | -zł62,900,243.00 | 32x | -23.1x | 3.3x |
| Mon, 17 Feb 2025 | zł1.7b | zł427.0m | -zł64,267,017.00 | 15.6x | -26.3x | 4x |
| Wed, 15 Jan 2025 | zł1.8b | zł427.0m | -zł65,964,174.00 | 15.6x | -27.3x | 4.2x |
| Fri, 13 Dec 2024 | zł2.1b | zł427.0m | -zł65,964,174.00 | 17.8x | -32.1x | 5x |
| Sun, 10 Nov 2024 | zł2.2b | zł421.9m | -zł72,811,689.00 | 21.6x | -30.7x | 5.3x |
| Tue, 08 Oct 2024 | zł2.4b | zł413.2m | -zł64,500,689.00 | 22.5x | -37.7x | 5.9x |
| Thu, 05 Sep 2024 | zł2.4b | zł413.4m | -zł37,576,869.00 | 17.8x | -64.7x | 5.9x |
| Sat, 03 Aug 2024 | zł2.5b | zł413.5m | -zł32,092,283.00 | 18.6x | -77.7x | 6x |
| Mon, 01 Jul 2024 | zł2.5b | zł413.5m | -zł32,092,283.00 | 19.2x | -76.5x | 5.9x |
| Wed, 29 May 2024 | zł2.5b | zł413.5m | -zł32,092,283.00 | 18.9x | -78.6x | 6.1x |
| Fri, 26 Apr 2024 | zł2.5b | zł421.0m | -zł26,364,957.00 | 17.9x | -93.7x | 5.9x |
| Sun, 24 Mar 2024 | zł2.5b | zł478.9m | -zł71,866,957.00 | 47x | -35.4x | 5.3x |
| Tue, 20 Feb 2024 | zł2.5b | zł495.9m | -zł52,637,957.00 | 44.4x | -48.1x | 5.1x |
| Thu, 18 Jan 2024 | zł2.5b | zł495.2m | -zł50,454,191.00 | 45.1x | -48.7x | 5x |
| Sat, 16 Dec 2023 | zł2.7b | zł495.2m | -zł50,454,191.00 | 46.8x | -52.9x | 5.4x |
| Mon, 13 Nov 2023 | zł2.5b | zł511.9m | -zł35,664,342.00 | 31x | -69.1x | 4.8x |
| Wed, 11 Oct 2023 | zł2.8b | zł512.0m | -zł37,354,934.00 | 33.1x | -74.7x | 5.5x |
| Fri, 08 Sep 2023 | zł2.7b | zł507.5m | -zł51,266,934.00 | 41.6x | -53.4x | 5.4x |
| Sun, 06 Aug 2023 | zł2.9b | zł512.4m | -zł61,559,268.00 | 47.1x | -46.9x | 5.6x |
| Tue, 04 Jul 2023 | zł2.8b | zł512.4m | -zł61,559,268.00 | 43.2x | -44.9x | 5.4x |
| Thu, 01 Jun 2023 | zł2.8b | zł504.7m | -zł60,194,797.00 | 44.8x | -46x | 5.5x |
| Sat, 29 Apr 2023 | zł2.8b | zł505.4m | -zł64,921,034.00 | 66.8x | -43.1x | 5.5x |
Price to Earnings Ratio
-43.1x
Current Industry PE
- Investors are pessimistic on the Polish Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 4.5x is higher than the industry's current PS ratio of 2.8x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have deteriorated over the last three years.
- Revenues have also declined 3.2% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the Polish Healthcare industry?
| PL Market | -0.27% | |
| Healthcare | -1.57% | |
| Life Sciences | 3.31% | |
| Clinical Research and Equipment | 3.31% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SLV Selvita | zł35.00 | 6.1% +zł36.7m | 10.1% | PE790.2x |